Ann S. Hamilton, PhD

Research Professor of Population and Public Health Sciences (Part-Time)

Image of Ann S. Hamilton, PhD
Is this your profile? Click to edit

Overview

Dr. Hamilton is a cancer epidemiologist with an interest in etiology of cancer as well as in cancer outcomes research. She has conducted several studies of prostate cancer survivors using cases obtained from the Los Angeles County SEER registry. Specifically, she was the Los Angeles PI for the Prostate Cancer Outcomes study which followed men for 15 years after diagnosis and was also the site PI for the CEASAR cohort which obtained treatment and outcome data for men diagnosed in 2011. In addition, she is leading the Los Angeles component of the PC Concept study which is designed to assess treatment related effects from newer prostate cancer treatment methods including focal therapy and SBRT. She has played a major role in analyzing the prostate patterns of care data from a multi-site CDC study as well as from SEER Patterns of Care data on prostate cancer. She has been the recruitment core lead for the RESPOND Study (C. Haiman, PI) that has already recruited 12,500 African American men with prostate cancer nationwide, has obtained 7,000 saliva/germline DNA samples and 2,800 tumor tissue samples. In addition she has led and participated in studies of thyroid cancer, adolescent and young adult cancer, as well as breast and ovarian cancer. Currently she is also involved with studies regarding genetic testing for cancer patients and how this information is relayed to relatives.

Awards

  • UCLA: Delta Omega Public Health Honor Society, 1986
  • UCLA: University of California National Institutes of Health Trainee,, 1982
     – 1985

Education and Training

  • Carleton College, Northfield, MN — BA — 06/70 — Biology
  • Georgetown University, Washington, DC — MA — 6/74 — Demography
  • University of California, Los Angeles — Ph.D. — 6/87 — Public Health, Epidemiology

Research Funding

  • Risk stratified survivorship care pathways for early-onset colorectal cancer
    NCI · Mar 21, 2023 – Feb 29, 2028 · Role: Los Angeles Subcontract PI, co-investigator
  • Multilevel Mechanisms of Racial/Ethnic Disparities in Early-Stage Lung Cancer Treatment: The Role of patient, provider, and geographical-level Factors
    ACS · Jan 1, 2023 – Dec 31, 2027 · Role: Co-investigator
  • A Registry Based Study of patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
    NCI · May 1, 2021 – Oct 31, 2025 · Role: Los Angeles Subcontract PI, co-investigator
  • 10-year Comparative Effectiveness and Harms of Treatments for Prostate Cancer
    NCI · Apr 1, 2021 – Mar 31, 2025 · Role: Co-Investigator, Los Angeles Subcontract PI
  • Project Milestones: Young Adult Cancer Survivorship
    NCI · Jan 1, 2021 – Dec 31, 2025 · Role: Co-investigator, USC subcontract PI
  • Prostate Cancer Comparative Outcomes of New Conceptual Paradigms for Treatment
    PCORI · Nov 1, 2020 – Oct 31, 2024 · Role: Los Angeles Subcontract PI, Co-PI
  • A population based virtual solution to reduce gaps in genetic risk evaluation and management in families at high risk for hereditary cancer syndromes: the Georgia/California gene link trial
    NCI · Sep 1, 2020 – Aug 31, 2025 · Role: Los Angeles Subcontract PI, co-investigator
  • Gaps in Genetic Risk Prevention in Breast Cancer Patients and Their Family
    ACS · Sep 1, 2020 – Aug 31, 2024 · Role: Los Angeles Subcontract PI, Co-investigator
  • Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Immunity and Stress (RESPOND)
    NCI/NIMHD/PCF · Jul 1, 2019 – Jun 30, 2024 · Role: Co-investigator, Recruitment Core Lead

Research Keywords

  • Cancer outcomes research
  • Prostate cancer
  • Breast cancer
  • Genetic testing
  • Cancer registries
  • Survey methods
  • Health disparities

Publications

  • Female-specific hypertension risk factors across the lifecourse: a co-twin control analysis using the California Twin Program. Am J Epidemiol. 2026 Jul 08; 195(7):1944-1961.. View in PubMed
  • Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants. JCO Precis Oncol. 2026 Jun; 10(6):e2600041.. View in PubMed
  • Adverse childhood experiences, adult adiposity, and risk of young-onset breast cancer subtypes in a population-based case-control study. Cancer Causes Control. 2026 May 26; 37(6).. View in PubMed
  • Patient-reported duplication and missed breast cancer survivorship care more than 5 years after initial treatment. J Cancer Surviv. 2026 May 11.. View in PubMed
  • Results From the Genetic Information and Family Testing Study: A Cluster-Randomized Trial. J Clin Oncol. 2026 May; 44(13):1216-1224.. View in PubMed
  • Symptom burden among long-term survivors of young adult cancer: a report from the Project Milestones cohort. J Cancer Surviv. 2026 Feb 20.. View in PubMed
  • Patient Engagement With Clinicians and Family Members About Genetic Test Results Across Risk Groups in Women With Hereditary Cancer Susceptibility. JCO Oncol Pract. 2026 Jan 13.. View in PubMed
  • Changes in patient-reported primary care engagement in and communication about survivorship care from initial breast cancer treatment to longer-term survivorship. Cancer. 2025 Dec 01; 131(23):e70181.. View in PubMed
  • Consensus guidelines for antibacterial prophylaxis in patients with neutropenia. Intern Med J. 2025 12; 55.. View in PubMed
  • Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory. Mol Diagn Ther. 2026 01; 30(1):137-148.. View in PubMed
  • Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 09 01; 11(9):982-989.. View in PubMed
  • Extended endocrine therapy use and decision making after breast cancer diagnosis. J Natl Cancer Inst. 2025 Aug 01; 117(8):1573-1582.. View in PubMed
  • Associations between childhood socioeconomic characteristics, race, and risk of adverse childhood experiences in a population-based sample of US-born non-Hispanic Black and White women. BMC Public Health. 2025 May 02; 25(1):1636.. View in PubMed
  • Trends in Practice Patterns and Clinical Outcomes for Desmoid Tumors: A Large Single-Institutional Australian Cohort. Cancer Med. 2025 May; 14(10):e70973.. View in PubMed
  • Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2. J Clin Oncol. 2025 05; 43(13):1587-1596.. View in PubMed
  • The Genetic Information and Family Testing (GIFT) study: trial design and protocol. BMC Cancer. 2025 Feb 27; 25(1):366.. View in PubMed
  • Race and Ethnicity, Lifestyle, Diet, and Survival in Patients With Prostate Cancer. JAMA Netw Open. 2025 02 03; 8(2):e2460785.. View in PubMed
  • Impacts of EPA’s finalized power plant greenhouse gas standards. Science. 2025 01 10; 387(6730):140-143.. View in PubMed
  • Patient-reported functional outcomes and treatment-related regret in Hispanic and Spanish-speaking men following prostate cancer treatment. Urol Oncol. 2025 04; 43(4):271.e19-271.e28.. View in PubMed
  • Oncology and Primary Care Involvement in Breast Cancer Survivorship Care More Than 5 Years After Initial Treatment. JCO Oncol Pract. 2025 Jun; 21(6):791-800.. View in PubMed
  • Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ. Breast Cancer Res. 2024 Dec 04; 26(1):178.. View in PubMed
  • Adiposity throughout Adulthood and Risk of Young-Onset Breast Cancer Tumor Subtypes in the Young Women’s Health History Study. Cancer Epidemiol Biomarkers Prev. 2024 12 02; 33(12):1659-1670.. View in PubMed
  • Prostate Cancer Disparities in Clinical Characteristics and Survival among Black and Latino Patients Considering Nativity: Findings from the California Cancer Registry. Cancer Epidemiol Biomarkers Prev. 2024 Nov 01; 33(11):1512-1522.. View in PubMed
  • Association between smoking and prostate cancer survivors’ long-term quality of life and function: an analysis of the CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) study. J Cancer Surviv. 2026 Jun; 20(3):858-869.. View in PubMed
  • Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer. J Clin Oncol. 2024 09 10; 42(26):3123-3129.. View in PubMed
  • Functional Outcomes After Localized Prostate Cancer Treatment. JAMA. 2024 01 23; 331(4):302-317.. View in PubMed
  • Clinical Impact of Comprehensive Molecular Profiling in Adolescents and Young Adults with Sarcoma. J Pers Med. 2024 Jan 23; 14(2).. View in PubMed
  • Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry. Cancer Res Commun. 2023 12 14; 3(12):2544-2550.. View in PubMed
  • Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer. Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):809.. View in PubMed
  • Lifetime alcohol consumption patterns and young-onset breast cancer by subtype among Non-Hispanic Black and White women in the Young Women’s Health History Study. Cancer Causes Control. 2024 Feb; 35(2):377-391.. View in PubMed
  • Germline Genetic Testing After Cancer Diagnosis. JAMA. 2023 07 03; 330(1):43-51.. View in PubMed
  • Emissions and energy impacts of the Inflation Reduction Act. Science. 2023 Jun 30; 380(6652):1324-1327.. View in PubMed
  • Factors Associated With Agreement Between Parent and Childhood Cancer Survivor Reports on Child’s Health Related Quality of Life. Eval Health Prof. 2024 Sep; 47(3):328-335.. View in PubMed
  • Primary care provider attitudes about and tendency to use non-recommended surveillance tests after curative breast cancer treatment. Breast Cancer Res Treat. 2023 Aug; 200(3):391-398.. View in PubMed
  • Targeting homologous recombination deficiency in uterine leiomyosarcoma. J Exp Clin Cancer Res. 2023 May 04; 42(1):112.. View in PubMed
  • Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer. Prostate Cancer Prostatic Dis. 2023 Mar; 26(1):214.. View in PubMed
  • Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nat Genet. 2023 03; 55(3):437-450.. View in PubMed
  • Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type. J Am Acad Dermatol. 2023 04; 88(4):831-840.. View in PubMed
  • Prevalence and correlates of skin examination among ethnically diverse young adult survivors of childhood cancer. Cancer Med. 2023 04; 12(7):8557-8566.. View in PubMed
  • Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer. Prostate Cancer Prostatic Dis. 2023 12; 26(4):787-794.. View in PubMed
  • Reply by Authors. J Urol. 2022 12; 208(6):1239.. View in PubMed
  • Association between body mass index and localized prostate cancer management and disease-specific quality of life. BJUI Compass. 2023 Mar; 4(2):223-233.. View in PubMed
  • The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer. JNCI Cancer Spectr. 2022 11 01; 6(6).. View in PubMed
  • A Systematic Review and Meta-Analysis of Smoking and Circulating Sex Hormone Levels Among Premenopausal Women. Nicotine Tob Res. 2022 10 26; 24(11):1705-1713.. View in PubMed
  • Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study. J Urol. 2022 Dec; 208(6):1226-1239.. View in PubMed
  • Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women’s Health History Study. Breast Cancer Res Treat. 2022 Oct; 195(3):353-366.. View in PubMed
  • Chemotherapy Regimens Received by Women With BRCA1/2 Pathogenic Variants for Early Stage Breast Cancer Treatment. JNCI Cancer Spectr. 2022 07 01; 6(4).. View in PubMed
  • Localized prostate cancer: An analysis of the Centers for Disease Control and Prevention Breast and Prostate Cancer Data Quality and Patterns of Care study (CDC PoC-BP). Can Urol Assoc J. 2022 Jul; 16(7):E391-E398.. View in PubMed
  • Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient Benefit. Cancers (Basel). 2022 Mar 18; 14(6).. View in PubMed
  • Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes. J Urol. 2022 05; 207(5):1029-1037.. View in PubMed
  • Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer. Prostate Cancer Prostatic Dis. 2023 03; 26(1):80-87.. View in PubMed
  • Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities. J Clin Endocrinol Metab. 2022 02 17; 107(3):e1096-e1105.. View in PubMed
  • Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer. J Natl Cancer Inst. 2022 02 07; 114(2):245-253.. View in PubMed
  • Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer. JAMA Oncol. 2022 Jan 01; 8(1):50-59.. View in PubMed
  • Factors Associated with Interest in Complementary and Alternative Medicine Among Young Adult Survivors of Childhood Cancer. J Pediatr Hematol Oncol Nurs. 2022 Jan-Feb; 39(1):30-39.. View in PubMed
  • Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes. JCO Precis Oncol. 2021; 5.. View in PubMed
  • Perceived financial decline related to breast reconstruction following mastectomy in a diverse population-based cohort. Cancer. 2022 03 15; 128(6):1284-1293.. View in PubMed
  • Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):404-412.. View in PubMed
  • Acculturation discrepancy and mental health associations among Hispanic childhood cancer survivors and their parents. Psychooncology. 2022 05; 31(5):761-769.. View in PubMed
  • Evaluating the Impact of Social and Built Environments on Health-Related Quality of Life among Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):161-174.. View in PubMed
  • Change in worry over time among Hispanic women with thyroid cancer. J Cancer Surviv. 2022 08; 16(4):844-852.. View in PubMed
  • Patterns of Cancer Care and Association with Survival among Younger Adolescents and Young Adults: A Population-Based Retrospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 2021 11; 30(11):2105-2113.. View in PubMed
  • A Population-Based Analysis of 30-Year Mortality among Five-Year Survivors of Adolescent and Young Adult Cancer: The Roles of Primary Cancer, Subsequent Malignancy, and Other Health Conditions. Cancers (Basel). 2021 Aug 05; 13(16).. View in PubMed
  • Theory, methods, and operational results of the Young Women’s Health History Study: a study of young-onset breast cancer incidence in Black and White women. Cancer Causes Control. 2021 Oct; 32(10):1129-1148.. View in PubMed
  • Acculturation, Mental Health, and Wellbeing Among Hispanic/Latinx Young Adult Survivors of Childhood Cancer. J Adolesc Young Adult Oncol. 2022 04; 11(2):223-228.. View in PubMed
  • Project Forward: A Population-Based Cohort Among Young Adult Survivors of Childhood Cancers. JNCI Cancer Spectr. 2021 10; 5(5).. View in PubMed
  • Surgeons’ Attitudes on Total Thyroidectomy vs Lobectomy for Management of Papillary Thyroid Microcarcinoma. JAMA Otolaryngol Head Neck Surg. 2021 07 01; 147(7):667-669.. View in PubMed
  • Barriers to Physician-Based Skin Examinations for Adolescent and Young Adult Survivors of Melanoma in the Project Forward Study. JAMA Dermatol. 2021 07 01; 157(7):874-876.. View in PubMed
  • Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort. Urol Oncol. 2022 02; 40(2):56.e1-56.e8.. View in PubMed
  • Unmet Information Needs Among Hispanic Women with Thyroid Cancer. J Clin Endocrinol Metab. 2021 06 16; 106(7):e2680-e2687.. View in PubMed
  • Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function. Prostate Cancer Prostatic Dis. 2022 02; 25(2):238-247.. View in PubMed
  • Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer. J Clin Endocrinol Metab. 2021 05 13; 106(6):e2402-e2412.. View in PubMed
  • Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study. Thyroid. 2021 09; 31(9):1383-1390.. View in PubMed
  • Racial/Ethnic Disparities in Patient Experiences With Health Care in Association With Earlier Stage at Colorectal Cancer Diagnosis: Findings From the SEER-CAHPS Data. Med Care. 2021 04 01; 59(4):295-303.. View in PubMed
  • Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer. Cancer. 2021 06 01; 127(11):1912-1925.. View in PubMed
  • Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019. J Clin Oncol. 2021 05 20; 39(15):1631-1640.. View in PubMed
  • Parental Cancer-related Information Seeking, Health Communication and Satisfaction with Medical Providers of Childhood Cancer Survivors: Differences by Race/Ethnicity and Language Preference. J Health Commun. 2021 02 01; 26(2):83-91.. View in PubMed
  • Physician Confidence in Neck Ultrasonography for Surveillance of Differentiated Thyroid Cancer Recurrence. JAMA Otolaryngol Head Neck Surg. 2020 Dec 23.. View in PubMed
  • Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer. J Urol. 2021 03; 205(3):761-768.. View in PubMed
  • A cross-sectional examination of caregiver mental health and childhood cancer survivors’ tobacco, alcohol, and marijuana use. Support Care Cancer. 2021 Jul; 29(7):3649-3656.. View in PubMed
  • Using Genomic Sequencing to Explain an Exceptional Response to Therapy in a Malignant Phyllodes Tumor. JCO Precis Oncol. 2020 Nov; 4:1263-1266.. View in PubMed
  • Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey. Ann Surg. 2022 07 01; 276(1):e40-e47.. View in PubMed
  • Physician-Reported Misuse of Thyroid Ultrasonography. JAMA Surg. 2020 10 01; 155(10):984-986.. View in PubMed
  • Financial Hardship Among Hispanic Women with Thyroid Cancer. Thyroid. 2021 05; 31(5):752-759.. View in PubMed
  • Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes. JNCI Cancer Spectr. 2021 02; 5(1).. View in PubMed
  • Physician management of thyroid cancer patients’ worry. J Cancer Surviv. 2021 06; 15(3):418-426.. View in PubMed
  • Relationships between parent and adolescent/young adult mental health among Hispanic and non-Hispanic childhood cancer survivors. J Psychosoc Oncol. 2020 Nov-Dec; 38(6):746-760.. View in PubMed
  • Primary Care Provider Involvement in Thyroid Cancer Survivorship Care. J Clin Endocrinol Metab. 2020 09 01; 105(9).. View in PubMed
  • Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors. J Cancer Surviv. 2021 04; 15(2):213-223.. View in PubMed
  • Estimating cancer treatment intensity from SEER cancer registry data: methods and implications for population-based registry studies of pediatric cancers. Cancer Causes Control. 2020 Oct; 31(10):881-890.. View in PubMed
  • Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes. Urol Oncol. 2020 12; 38(12):930.e23-930.e32.. View in PubMed
  • Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study. Cancer Epidemiol Biomarkers Prev. 2020 09; 29(9):1699-1709.. View in PubMed
  • Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study. J Urol. 2020 12; 204(6):1236-1241.. View in PubMed
  • Patient Report of Recurrent and Persistent Thyroid Cancer. Thyroid. 2020 09; 30(9):1297-1305.. View in PubMed
  • Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives. Plast Reconstr Surg. 2020 04; 145(4):865-876.. View in PubMed
  • Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer. JAMA Oncol. 2020 04 01; 6(4):e196400.. View in PubMed
  • Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care. Gynecol Oncol. 2020 06; 157(3):793-798.. View in PubMed
  • Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation. Eur Urol. 2020 08; 78(2):248-255.. View in PubMed
  • Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer. JAMA. 2020 01 14; 323(2):149-163.. View in PubMed
  • Disparities in risk perception of thyroid cancer recurrence and death. Cancer. 2020 04 01; 126(7):1512-1521.. View in PubMed